CastleArk Alternatives’s Cerence CRNC Stock Holding History

CastleArk Alternatives’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-103,046	Closed	-$9.9M	–	75
2021 Q3	$9.9M	Buy	+103,046	New	+$11.2M	0.38%	75

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

CastleArk Alternatives's CRNC Position: Q4 2021 in Review

CastleArk Alternatives sold out of Cerence (CRNC) in Q4 2021, closing a stake of 103,046 shares — an estimated $9.9M sold.

CastleArk Alternatives first reported a position in CRNC in Q3 2021 and held it in 1 quarter. The position peaked at $9.9M in Q3 2021. 360 funds tracked by Wall St. Rank hold CRNC as of Q4 2021.

CastleArk Alternatives reported no remaining Cerence position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 103,046 Cerence shares in Q4 2021, an estimated $9.9M.
CastleArk Alternatives first reported a position in Cerence in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's Cerence position peaked at $9.9M in Q3 2021.
360 funds tracked by Wall St. Rank held Cerence as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.